Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email mava@mava.org.
 

 

Check back regularly for news, coverage, and announcements about MAVA.

  
Latest News:

03/14/2014 – Security firm Shadow Networks bags $10M in new funding round

Shadow Networks, formerly called ZanttZ Inc, has secured more than $10 million in a recent funding round, TechCrunch reported citing the company's filing to the US Securities and Exchange Commission.

03/13/2014 – Chevy Chase-Based NEA Co-Leads $50 Million Round for MuleSoft

New Enterprise Associates, the Chevy Chase-based venture capital firm, said on Thursday it has co-led a new $50 million round of funding for San Francisco-based MuleSoft, the developer of an integration platform designed to let users more easily connect applications, data and devices.

03/13/2014 – MuleSoft raises $50 million, preps for IPO

The round was co-led by New Enterprise Associates, Lightspeed Venture Partners, and Meritech Capital.

03/13/2014 – Basho Names New CEO and CTO

Basho, the creator and developer of Riak, the industry leading distributed NoSQL database, today announced that Adam Wray has joined the company as chief executive officer and Dave McCrory as chief technology officer.

03/12/2014 – High Street Partners Announces Strategic Partnership with Merrill Brink

High Street Partners (HSP) today announced that it has partnered with Merrill Brink.

03/12/2014 – Google Capital Leads $85M Credit Karma Funding Round

Credit Karma's ad-based free services model has attracted Google Capital as lead investor in the company's latest $85 million round of financing.

03/11/2014 – DataRPM Secures $5.1 Million In Series A

DataRPM, the industry pioneer in cognitive business intelligence, today announced that it has closed a $5.1 million Series A funding round.

03/11/2014 – NEA-backed TriVascular Files For IPO

TriVascular Technologies, Inc., manufacturer of the Ovation Prime(R) Abdominal Stent Graft System, announced that is has filed a registration statement on Form S-1 with the Securities and Exchange Commission relating to a proposed initial public offering of shares of its common stock.

03/11/2014 – NEA Leads $45M Series B For Lumena Pharmaceuticals

Lumena Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of novel products for rare cholestatic liver diseases and serious metabolic disorders, announced that it has secured $45 million in Series B financing.

03/11/2014 – Three Senior Professionals Join Signal Hill

Signal Hill, a independent advisory boutique serving the M&A and private capital raising needs of growth companies, is pleased to announce that Eric Edmondson, co-founder of Seven Hills Partners, a highly-regarded San Francisco-based independent investment banking advisory firm, has joined the firm as a Managing Director in its San Francisco office.

123456789101112131415161718192021222324252627282930   313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126